Abstract
Background Innovation in healthcare technologies can result in more convenient and effective treatment that is less costly, but a persistent challenge to widespread adoption in health and social care is end user acceptability. The purpose of this study was to capture UK public opinions and attitudes to novel healthcare technologies (NHTs), and to better understand the factors that contribute to acceptance and future use.
Methods An online survey was distributed to the UK public between April and May 2020. Respondents received brief information about four novel healthcare technologies (NHTs) in development: a laser-based tool for early diagnosis of osteoarthritis, a virtual reality tool to support diabetes self-management, a non-invasive continuous glucose monitor using microwave signals, a mobile app for patient reported monitoring of rheumatoid arthritis. They were queried on their general familiarity and attitudes to technology, and their willingness to accept each NHT in their future care. Responses were analysed using summary statistics and content analysis.
Results Knowledge about NHTs was diverse, with respondents being more aware about the health applications of mobile apps (66%), followed by laser-based technology (63.8%), microwave signalling (28%), and virtual reality (18.3%). Increasing age and the presence of a self-reported medical condition favoured acceptability for some NHTs, whereas self-reported understanding of how the NHT works resulted in elevated acceptance scores across all NHTs presented. Common contributors to hesitancy were safety and risks from use. Respondents wanted more information and evidence to help inform their decisions, ideally provided verbally by a general practitioner or health professional. Other concerns, such as privacy, were NHT-specific but equally important in decision-making.
Conclusions Early insight into the knowledge and preconceptions of the public about NHTs in development can assist their design and prospectively mitigate obstacles to acceptance and adoption.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded by the GW4 Crucible Seed Funding Award (Ref. no: Cru19_2). Sarah Sauchelli is supported by the NIHR Biomedical Research Centre at University Hospitals of Bristol and Weston NHS Foundation Trust and the University of Bristol. Tim Pickles is supported by a National Institute of Health Research (NIHR) Doctoral Fellowship, funded by the Welsh Government through Health and Care Research Wales (NIHR-FS-19). Heungjae Choi was a Ser Cymru II Fellowship part-funded by the European Regional Development Fund through the Welsh Government (No. TG/KJB/VSM:1103515) and was supported by the Engineering and Physical Sciences Research Council (EPSRC) under Grant GaN-DaME (EP/P00945X/1) during the duration of the project. Gemma Lasseter acknowledges support from the NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol. The views expressed are those of the authors and not necessarily those of the NIHR, the Department of Health and Social Care, or Public Health England.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the Faculty of Health Sciences Research Ethics Committee, University of Bristol (Ref: 94502).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
List of Abbreviations
- NHT
- Novel healthcare technology
- HCP
- Healthcare professional
- IMD
- Index of Multiple Deprivation
